期刊文献+

L-精氨酸防治大鼠高肺血流量所致肺动脉高压的研究 被引量:1

Preventive and Therapeutic Effects of L-Arginine on Pulmonary Hypertension Induced by High Pulmonary Blood Flow Volume in Rats
在线阅读 下载PDF
导出
摘要 目的 :研究L -精氨酸对高肺血流量所致肺动脉高压的防治作用。方法 :将雄性SD大鼠随机分为对照组 (n=6)、分流组(n=7)和分流 +L -精氨酸组 (n=8)。以腹主动脉 -下腔静脉分流术造成大鼠左向右分流。11周后 ,以右心导管法测定肺动脉平均压 (mPAP) ,并观测肺血管结构及平滑肌细胞PCNA的表达。结果 :分流组大鼠mPAP明显高于对照组 (P均<0 01) ,并且分流组大鼠肺小血管肌化程度明显增强 ,肺中、小肌型动脉相对中膜面积明显增加。11周分流组大鼠肺中、小型动脉平滑肌细胞PCNA的表达明显高于11周对照组大鼠 (P<0 05)。L -精氨酸缓解了肺动脉高压及肺血管结构重建的形成。结论 :L -精氨酸对高肺血流量所致肺血管结构重建及肺动脉高压有重要的防治作用。 OBJECTIVE:To study the preventive and therapeutic actions of L-arginine on pulmonary hypertension induced by high pulmonary blood flow volume.METHODS:Male SD rats were randomly divided into control group(n=6),shunt group (n=7) and shunt+L-arginine group(n=8).Abdominal aorta-inferior vena cava shunt was performed to make the blood flow from left to right,11 weeks later,mPAP was detected with right cardiac catheter;the structure of pulmonary vessels and expression of PCNA of smooth muscle cells were observed.RESULTS:The mPAP of shunt group was obviously higher than that of control(P<0.01);the organization of pulmonary small vessels was obvious and relative area of tunica media of pulmonary middle and small arteries markedly increased;expression of PCNA of smooth muscle cell of pulmonary middle and small arteries was obviously higher than that of control (P<0.05).L-arginine slowed down pulmonary hypertension and reconstruction of pulmonary vessels.CONCLUSION:L-arginine has preventive and therapeutic effects on reconstruction of pulmonary vessels and pulmonary hypertension induced by high pulmonary blood flow volume.
出处 《中国药房》 CAS CSCD 2003年第1期13-14,共2页 China Pharmacy
基金 国家自然科学基金资助项目 (30070796) 卫生部科学研究基金资助项目 (98-1-261) 北京市自然科学基金资助项目 (7012021)
关键词 L-精氨酸 肺动脉高压 左向右分流 预防 治疗 动物实验 L-arginine pulmonary hypertension left-right shunt
  • 相关文献

参考文献3

二级参考文献9

共引文献50

同被引文献9

  • 1McLaughlin W, Archer SL, Badesch DB, et al. ACCF/ AlIA 2009 expert consensus document on pulmonary hy- pertension[J]. JAm Coil Cardiol, 2009,53 (17) : 1573.
  • 2Simonneau G, Robbins IM, Beghetti M, et al.Updated clinical classification of pulmonary hypertension[J]. J Am Coil Cardiol, 2009,54 (Suppl 1 ) : 43.
  • 3Carroll WD, Dhillon R.Sildenafil as a treatment for pulmonary hypertension [J].Arch Dis Child, 2003,88 (9) : 827.
  • 4Wang C, Wang J, Zhao L, et al.Sildenafil inhibits human pulmonary artery smooth muscle cell proliferation by decreasing capacitative Ca2 + entry [J].J Pharmacol Sci, 2008,108(1) :71.
  • 5Li B, Yang L, Shen J, et al. The antiproliferative effect of sildenafil on pulmonary artery smooth muscle cells is mediated via upregulation of mitogen-activated protein kinase phosphatase-1 and degradation of extracellular signal-regulated kinase 1/2 phosphorylation [J]. Anesth Analg,2007,105(4) : 1 034.
  • 6Sastry BKS, Narasimhan C, Reddy K, et al.Clinical efficacy of sildenafil in primary pulmonary hypertension[J].J Am Coll Cardiol,2004,43(7) : 1 149.
  • 7Galie N, Humbert M, Vachiery JL, et al. Effects ofberaprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial[J]. J Am Coll Cardiol, 2002,39(9) : 1 496.
  • 8Itoh T, Nagaya N, Fujii T, et al.A combination of oral sildenafil and beraprost ameliorates pulmonary hyperten- sion in rats [J]. Am J Respir Crit Care Med, 2004, 169 (1):34.
  • 9Ikeda D, Tsujino I, Ohira H, et al. Addition of oral sildenafil to beraprost is a safe and effective therapeutic option for patients with pulmonary hypertension[J]. J Cardiovasc Pharmacol, 2005,45 (4) : 286.

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部